Towards Healthcare
Diabetes Management Apps Market
Updated Date: 15 December 2025   |   Report Code: 6510

Diabetes Management Apps Market Industry Gaining Global Momentum

Projections indicate that, the global diabetes management apps market will increase from USD 1.93 billion in 2025 to USD 4.38 billion by 2035, experiencing a CAGR of 8.54% over the next 10 years. The applications are vital to resolve the complexity of self-care, improve glycemic control, bridge gaps in healthcare access, and address challenges in diabetes management.

Last Updated : 15 December 2025 Category: Healthcare IT Insight Code: 6510 Format: PDF / PPT / Excel
Revenue, 2025
1.93 Billion
Forecast, 2035
4.38 Billion
CAGR, 2026-2035
8.54%
Report Coverage
Global

The global diabetes management apps market size was estimated at USD 1.93 billion in 2025 and is predicted to increase from USD 2.09 billion in 2026 to approximately USD 4.38 billion by 2035, expanding at a CAGR of 8.54% from 2026 to 2035.

Diabetes Management Apps Market Trends and Growth (2026)

The diabetes management apps market is accelerated by the introduction of versatile applications such as Gluroo, Glucose Buddy, mySugr, Diabetes: M, Health2Sync, and many others to manage diabetes effectively. These applications help diabetes patients track their meals, see blood sugar changes, auto-sync blood glucose data, and understand their blood sugar.

Key Takeaways

  • Diabetes management apps sector pushed the market to USD 2.09 billion by 2026.
  • Long-term projections show USD 4.38 billion valuation by 2035.
  • Growth is expected at a steady CAGR of 8.54% in between 2026 to 2035.
  • North America dominated the diabetes management apps market in 2025, with a revenue share of 35%.
  • Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
  • By product type, the blood glucose monitoring apps segment dominated the market in 2025, with a revenue share of 40%.
  • By product type, the diet & lifestyle management apps segment in the market is expected to grow at the fastest CAGR during the forecast period.
  • By deployment type, the cloud-based segment dominated the market in 2025, with a revenue share of 55%, and is expected to grow at the fastest CAGR in the market during the forecast period.
  • By application, the blood glucose monitoring & management segment dominated the diabetes management apps market in 2025, with a revenue share of 45%.
  • By application, the diet & lifestyle optimization segment is expected to witness the fastest growth during the forecast period.
  • By technology/mode of action, the mobile & web platforms segment dominated the market in 2025, with a revenue share of 35%.
  • By technology/mode of action, the AI & machine learning-based analytics segment is expected to witness the fastest growth during the forecast period.
  • By end-user, the individual patients/consumers segment dominated the diabetes management apps market in 2025, with a revenue share of 50%.
  • By end-user, the pharmaceutical & biotech companies segment is expected to witness the fastest growth during the forecast period.

Quick Facts Table

Key Elements Scope
Market Size in 2026 USD 2.09 Billion
Projected Market Size in 2035 USD 4.38 Billion
CAGR (2026 - 2035) 8.54%
Leading Region North America by 35%
Market Segmentation By Product Type, By Deployment Type, By Application, By Technology/Mode of Action, By End-User, By Region
Top Key Players Roche, Teladoc Health, Omada Health, Azumio Inc., One Drop, Beat Diabetes, Glooko, Dexcom, Abbott, Medtronic

What are Diabetes Management Apps?

The diabetes management apps market refers to the global ecosystem of mobile and web-based applications designed to assist patients with diabetes in monitoring, managing, and improving their health outcomes. These apps offer functionalities such as blood glucose tracking, insulin dose calculation, medication reminders, diet and lifestyle management, remote patient monitoring, and integration with wearable devices. They aim to enhance patient adherence, optimize glycemic control, and provide actionable insights to both patients and healthcare providers. The market growth is driven by increasing prevalence of diabetes, rising smartphone adoption, advancements in digital health technologies, the growing emphasis on personalized care, and the integration of AI and analytics to improve disease management outcomes. 

How is AI impacting the Diabetes Management Apps Market?

AI-powered applications for diabetics help patients with designing their daily menu, reminding them to measure their blood glucose levels, and monitoring their activity during the entire day. These apps are vital in expanding the market due to their major role in predicting sugar levels based on the body’s response to certain factors, determining the right dose of insulin, and self-monitoring sugar levels.

  • Data Security and Regulatory Framework: The increased focus on robust data security measures and regulatory compliance helps to handle sensitive health data. The compliance is set with regulations like GDPR and HIPAA. It aims to establish trust and expand market access.
  • Over-the-Counter (OTC) Solutions: There are significant opportunities in the diabetes management apps market to access more user-friendly products for a large number of patients, including people with type 2 diabetes. The growing demand for personalized and data-driven health solutions will continue to grow significantly.

Health and Fitness Mobile Apps on Google Play Store & Apple App Store Between.

Major Investments in the Diabetes Management Apps Market

  • In October 2024, Glooko, the diabetes software company, secured $100 million to expand its diabetes management system across North America, the Middle East, and Asia.
  • In December 2025, Medtronic announced the U.S. commercial launch of the MiniMed 780G system integrated with the Instinct sensor for smart and seamless diabetes management, produced by Abbott Laboratories.

Segmental Insights

Product Type Insights

How does the Blood Glucose Monitoring Apps Segment Dominate the Diabetes Management Apps Market in 2025?

The blood glucose monitoring apps segment dominated the market in 2025, with a revenue share of 40%, owing to their common functions such as blood glucose monitoring, integration with measuring devices, diabetes education, and medication adherence reminders. They track diabetes risk factors and enable teleconsultation services. They improve communication with healthcare providers and result in better clinical outcomes.

Diet & Lifestyle Management Apps

The diet & lifestyle management apps segment is expected to grow at the fastest CAGR in the diabetes management apps market during the forecast period due to their major benefits in data tracking, monitoring, personalized guidance and feedback, education, and awareness. The potential features of these apps include a user-friendly interface, integration with devices, and evidence-based information. The robust data security and privacy measures protect sensitive personal health information to build patient trust.

Deployment Type Insights

What made Cloud-Based the Dominant Segment in the Diabetes Management Apps Market in 2025?

The cloud-based segment dominated the market in 2025, with a revenue share of 55%, owing to its offline functionality, real-time device integration, data privacy, and security. The integration with cloud-based systems facilitates real-time monitoring, trend analysis, and collaboration with a caregiver team. These systems give immediate feedback, allow automated data entry, and enable insulin dose calculation.

On-Premise/Local Installations

The on-premise/local installations segment is estimated to grow at a significant rate in the diabetes management apps market during the predicted timeframe due to the huge adoption of cloud-based solutions for centralized data management, enhanced accessibility, and real-time monitoring. The cloud-based systems facilitate collaborative care and improve scalability and interoperability. The cloud-based servers are capable of managing the computational power required for AI and ML algorithms.

Application Insights

How did the Blood Glucose Monitoring & Management Segment Dominate the Diabetes Management Apps Market in 2025?

The blood glucose monitoring & management segment dominated the market in 2025, with a revenue share of 45%, owing to the key features of diabetes-friendly applications such as automated data logging, monitoring, data analysis, and comprehensive tracking. These apps manage diabetes and empower patients to take complete self-care. The educational resources present in many apps aim to enhance the self-care management skills of patients and motivate users.

Diet & Lifestyle Optimization

The diet & lifestyle optimization segment is anticipated to grow at a notable rate in the diabetes management apps market during the upcoming period due to the efforts to empower patients with self-monitoring and tracking of their food and carbohydrate intake, blood glucose, and weight. Mobile Health applications give nutritional recommendations and diabetes education. They enhance communication and professional support through data sharing and remote coaching.

Technology/Mode of Action Insights

Which Segment by Technology/Mode of Action Dominated the Diabetes Management Apps Market in 2025?

The mobile & web platforms segment dominated the market in 2025, with a revenue share of 35%, owing to the increased focus on real-time patient self-management and data collection. The web platforms facilitate clinician-led remote patient monitoring and detailed data analysis. They provide clinical decision support and conduct detailed review and analysis of data.

The AI & machine learning-based analytics segment is predicted to grow at a rapid rate in the diabetes management apps market during the studied period due to their assistance in personalized treatment plans, automated insulin delivery systems, and early warning systems. They enable smart monitoring, data analysis, and lifestyle and dietary management. They help in risk assessment, screening complications, and enhancing patient engagement.

End-User Insights

Why did the Individual Patients/Consumers Segment dominate the Diabetes Management Apps Market in 2025?

The individual patients/consumers segment dominated the market in 2025, with a revenue share of 50%, owing to seamless communication with healthcare providers, data-driven decision-making, and self-monitoring benefits offered by digital health applications. They help people with informed decision-making, education, and support. They serve as convenient and powerful tools that improve long-term health outcomes.

The pharmaceutical & biotech companies segment is predicted to grow at a rapid rate in the diabetes management apps market during the studied period due to the increased focus on improving medication adherence and outcomes, real-world data collection, and accelerating R&D. The partnerships between pharmaceutical companies and digital health startups aim to leverage technology and expertise. The improved R&D helps to design more targeted medications.

Regional Distribution

Diabetes Management Apps Market Share, By Region, 2025 (%)

  • North America registered dominance in the diabetes management apps market in 2025 with a revenue share of 35%.
  • The U.S. led the market by capturing the largest revenue share of the market in 2025. 
  • Asia Pacific is expected to be the fastest-growing region in the studied years. 
  • India is anticipated to grow at a rapid CAGR during the forecast period.
  • Europe is expected to grow at a significant CAGR in the diabetes management apps market during the forecast period.
  • Germany is anticipated to grow at a rapid CAGR during the forecast period.

How does North America Dominate the Diabetes Management Apps Market in 2025?

North America dominated the market in 2025, owing to the rising diabetes population, a supportive healthcare system, and policies. In December 2024, the American Diabetes Association (ADA) announced that it had been selected as the winner for the 2024–2025 Amazon Web Services IMAGINE Grant for Nonprofits for using technologies to solve the most powerful challenges in the world. In November 2025, the Pan American Health Organization (PAHO) launched new resources on the occasion of World Diabetes Day to strengthen the diagnosis, treatment, and control of diabetes in primary healthcare, further expanding the diabetes management apps market.

The Trump Administration partnered with Big Tech to introduce a health data tracking program. The initiative will also focus on diabetes and weight management, digital tools such as QR codes and apps, and conversational AI. Recently, Senseonics, situated in Maryland, USA, signed an MoU with Ascensia Diabetes Care to accelerate the commercialization and distribution of a glucose monitor named Eversense 365.

What is the Potential of the Diabetes Management Apps Market in the Asia Pacific?

Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period due to high smartphone and internet penetration and the growing focus on self-management. The Asian Pacific countries, like India, Singapore, South Korea, Indonesia, and Taiwan, have launched government programs involving collaborations among private tech and healthcare companies. These initiatives focus on integrating devices and apps into national healthcare systems to encourage the massive growth of the diabetes management apps market.

In October 2024, the Watershed Development Fund (WDF), the World Health Organization (WHO), and the Government of India collaborated through a national project to strengthen global non-communicable disease (NCDs) care. India’s healthcare startups focus on adopting AI and wearables to help manage the country’s disease crisis.

How is the Notable Growth of Europe in the Diabetes Management Apps Market?

Europe is expected to grow at a notable rate in the market in 2025, led by the growing adoption of connected devices, demand for remote healthcare, and increased digital health literacy. The European Union and the European Commission run EU4Health projects that work on diabetes prevention, further expanding the diabetes management apps market. In June 2025, IBM and Roche launched innovative solutions to support people dealing with diabetes in their daily routine with AI-enabled glucose predictions.

In October 2025, Diamontech, situated in Germany, secured EUR 12 million to transform diabetes management with needle-free technology. Germany built a national system for reimbursement of digital health applications for diabetes management. The country focuses on application inclusion, app delisting, and program evolution.

Revenue of Health and Fitness Mobile Apps on Google Play Store & Apple App.

Top Vendors in the Diabetes Management Apps Market & their Offerings

Diabetes Management Apps Market Key Players

Sr. No. Name of the Company Headquarter Latest Update
1 Roche Vienna, Austria In September 2025, Roche expanded AI-enabled Accu-Chek SmartGuide CGM by integrating the mySugr app across Asia Pacific, Europe, and Latin America.
2 Teladoc Health Purchase, New York Teladoc Health introduced a diabetes management program to offer personalized support from certified diabetes education and care specialists.
3 Omada Health San Francisco, California, U.S. In August 2025, Omada Health reported revenue of $61 million for the second quarter.
4 Azumio Inc. Palo Alto, California, USA Azumio Inc. is committed to creating next-generation health applications with its AI-powered solutions.
5 One Drop New York City, USA One Drop improved productivity for workers with type 2 diabetes.
6 Beat Diabetes Dubai, United Arab Emirates In October 2025, Beat Diabetes, the Gurugram-based nutritionist, introduced 9 veggies that control blood sugar and fight insulin resistance.
7 Glooko Palo Alto, California, USA In October 2025, Glooko made efforts to easily sync health data and fitness for better diabetes management.
8 Dexcom San Diego, California, U.S.A In September 2025, Dexcom Inc. issued a correction for G7 apps and ONE+ apps due to errors in software design.
9 Abbott Chicago, Illinois, USA Abbott moved forward to advance diabetes care through technology and nutrition.
10 Medtronic Dublin, Ireland  In May 2025, Medtronic reported its intent to separate its diabetes business.

SWOT Analysis

Strength

  • There is a seamless integration with connected devices, and AI and ML-driven personalization.
  • The digital health applications are driving the diabetes management apps market through enhanced user experience and patient engagement.
  • Patients are able to achieve improved glycemic control through detailed data management and analytics.

Weakness

  • Potential concerns arise in the diabetes management apps market with data accuracy, a lack of regulation, and data management.
  • The limited clinical and psychological support creates challenges in problem-solving and promoting healthy coping mechanisms.
  • A lack of long-term support and business models also creates potential limitations.

Opportunity

  • These include technological integration, enhanced care models, user experience, market and regional expansion, and investment areas.
  • The startups and innovation focus on innovative solutions such as AI-driven apps.
  • There is an increased focus on addressing data security and privacy concerns to build user trust and ensure regulatory compliance.

Threats

  • There are certain threats related to cybersecurity, third-party data sharing, and vulnerabilities in connected devices, limiting the growth of the diabetes management apps market.
  • The regulatory and compliance challenges arise due to a lack of standardization, a complex framework, and algorithmic bias in AI.
  • The clinical and operational issues are associated with high costs, reimbursement issues, and unproven clinical claims.

Recent Developments in the Diabetes Management Apps Market

  • In June 2025, Omada Health’s initial public offering (IPO) targeted musculoskeletal and obesity care with a digital-first model, with an expected offering to raise $150.1 million.
  • In July 2025, Teladoc Health launched the WellBound employee assistance program to empower a healthier and more engaged workforce.

Segments Covered in the Report

By Product Type

  • Blood Glucose Monitoring Apps
    • Glucose tracking & reporting 
    • Insulin dose calculators
  • Diet & Lifestyle Management Apps
    • Meal tracking
    • Exercise and activity monitoring
  • Medication & Treatment Adherence Apps
    • Reminders & alerts 
    • Prescription management
  • Data Analytics & Reporting Apps
    • Trend analysis
    • Clinical reporting integration
  • Other Diabetes Apps
    • Gestational diabetes management 
    • Type 1 & Type 2 specific tools 

 By Deployment Type 

  • Cloud-Based
  • On-Premise/Local Installations
  • Hybrid (Cloud + Local)

By Application

  • Blood Glucose Monitoring & Management
  • Diet & Lifestyle Optimization
  • Medication & Treatment Adherence
  • Patient Engagement & Education 
  • Other Applications

 By Technology/Mode of Action

  • AI & Machine Learning-Based Analytics
  • Mobile & Web Platforms
  • IoT & Wearable Device Integration
  • Telehealth/Virtual Care Integration
  • Other Technologies

By End-User

  • Individual Patients/Consumers
  • Hospitals & Health Systems
  • Pharmaceutical & Biotech Companies
  • Insurance & Payers
  • Other End-Users 

By Region

  • North America
    • U.S.
    • Canada 
    • Mexico 
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe 
    • Western Europe 
      • Germany 
      • Italy
      • France
      • Netherlands
      • Spain
      • Portugal 
      • Belgium
      • Ireland
      • UK 
      • Iceland 
      • Switzerland
      • Poland
      • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
  • Asia Pacific
    • China 
    • Taiwan
    • India 
    • Japan 
    • Australia and New Zealand
    • ASEAN Countries (Singapore, Malaysia)
    • South Korea 
    • Rest of APAC 
  • MEA 
    • GCC Countries
      • Saudi Arabia 
      • United Arab Emirates (UAE)
      • Qatar 
      • Kuwait 
      • Oman 
      • Bahrain 
    • South Africa
    • Egypt 
    • Rest of MEA

FAQ's

Answer : The diabetes management apps market currently in 2026 records USD 2.09 billion and is anticipated to grow to USD 4.38 billion by 2035, advancing at a CAGR of 35% from 2026 to 2035.

Answer : North America is currently leading the diabetes management apps market  by 35% due to integration with wearable devices and high adoption of digital health solutions.

Answer : Some key players include Roche, Teladoc Health, Omada Health, One Drop, Glooko, Dexcom, and Abbott.

Tags

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar

Related Reports